Whole Blood DNA Extraction Methods Compared
|
By LabMedica International staff writers Posted on 14 Aug 2014 |
In the clinical laboratory, nucleic acids are routinely isolated from various types of specimen, including blood, sputum, cerebrospinal fluid, stool, urine, buccal swabs, and respiratory specimens, for use in a wide array of molecular diagnostic tests.
Both the quality and quantity of the extracted nucleic acids are crucial to the successful implementation of downstream molecular diagnostic procedures, including polymerase chain reaction (PCR), quantitative PCR, microarray analyses, and direct sequencing.
Laboratory scientists at the Asian Medical Center (Seoul, Republic of Korea) collected blood samples from five healthy donors and all DNA extraction processes were performed within six hours of specimen collection. The team evaluated the efficiency of three extraction methods by comparison based on the total amount of extracted DNA adjusted by input blood volume, and the purity of the extract. Polymerase chain reaction analyses were performed using the Actin Beta gene (ACTB) as a target. The real-time PCR assay was carried out for housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Total elapsed time for DNA extraction was compared.
The three extraction methods were the Nextractor NX-48 system, (Genolution; Seoul, Republic of Korea); the manual QIAamp DNA Blood Mini Kit (Qiagen; Valencia, CA, USA), and the automated Maxwell system method (Promega; Madison, WI, USA). Following DNA extraction, the optical density of each sample was read at 260 nm and 280 nm using a NanoDrop ND-2000c spectrophotometer (Thermo Scientific; Wilmington, DE, USA). Real-time PCR was run on a SmartCycler system (Cepheid; Sunnyvale, CA, USA).
Extraction efficiencies for the QIAamp was 25.4 ± 3.8 ng/μL, for the Maxwell it was 9.2 ± 0.6 ng/μL, and the Nextractor system was the most efficient at 31.0 ± 5.6 ng/μL. No significant differences in purity were observed among three methods. DNA extracted using the ACTB was successfully amplified in all three methods. There were no obvious differences in cycle threshold (Ct) values for GAPDH real-time PCR. Total elapsed time for DNA extraction was about 50 minutes for the QIAamp, 40 minutes for the Maxwell, and 20 minutes for the Nextractor.
The authors concluded that both the purity and yield of the Nextractor system were similar to that of manual extraction. The relative speed and low hands-on time represent clear benefits over manual processes. Therefore, the Nextractor system represents a useful alternative to manual DNA extraction in clinical laboratories that is suitable for many downstream molecular diagnostic applications. The study was published in the August 2014 issue of the journal Clinica Chimica Acta.
Related Links:
Asian Medical Center
Genolution
Cepheid
Both the quality and quantity of the extracted nucleic acids are crucial to the successful implementation of downstream molecular diagnostic procedures, including polymerase chain reaction (PCR), quantitative PCR, microarray analyses, and direct sequencing.
Laboratory scientists at the Asian Medical Center (Seoul, Republic of Korea) collected blood samples from five healthy donors and all DNA extraction processes were performed within six hours of specimen collection. The team evaluated the efficiency of three extraction methods by comparison based on the total amount of extracted DNA adjusted by input blood volume, and the purity of the extract. Polymerase chain reaction analyses were performed using the Actin Beta gene (ACTB) as a target. The real-time PCR assay was carried out for housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Total elapsed time for DNA extraction was compared.
The three extraction methods were the Nextractor NX-48 system, (Genolution; Seoul, Republic of Korea); the manual QIAamp DNA Blood Mini Kit (Qiagen; Valencia, CA, USA), and the automated Maxwell system method (Promega; Madison, WI, USA). Following DNA extraction, the optical density of each sample was read at 260 nm and 280 nm using a NanoDrop ND-2000c spectrophotometer (Thermo Scientific; Wilmington, DE, USA). Real-time PCR was run on a SmartCycler system (Cepheid; Sunnyvale, CA, USA).
Extraction efficiencies for the QIAamp was 25.4 ± 3.8 ng/μL, for the Maxwell it was 9.2 ± 0.6 ng/μL, and the Nextractor system was the most efficient at 31.0 ± 5.6 ng/μL. No significant differences in purity were observed among three methods. DNA extracted using the ACTB was successfully amplified in all three methods. There were no obvious differences in cycle threshold (Ct) values for GAPDH real-time PCR. Total elapsed time for DNA extraction was about 50 minutes for the QIAamp, 40 minutes for the Maxwell, and 20 minutes for the Nextractor.
The authors concluded that both the purity and yield of the Nextractor system were similar to that of manual extraction. The relative speed and low hands-on time represent clear benefits over manual processes. Therefore, the Nextractor system represents a useful alternative to manual DNA extraction in clinical laboratories that is suitable for many downstream molecular diagnostic applications. The study was published in the August 2014 issue of the journal Clinica Chimica Acta.
Related Links:
Asian Medical Center
Genolution
Cepheid
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Molecular Diagnostics News
- Portable Test Detects Zika and Hepatitis C RNA from Whole Blood
- DNA Methylation May Predict Treatment Response in Myelodysplastic Syndromes
- Blood-Based Test May Predict Response Across Rheumatoid Arthritis Drug Classes
- New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma
- Circulating Tumor DNA Test Identifies Complete Immunotherapy Responders
- Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes
- Studies Support MRD Testing to Detect Head and Neck Cancer Recurrence
- Nonendoscopic Methylation Assay Enables Rapid Barrett’s Esophagus Screening
- AI-Supported Approach May Improve Cervical Cancer Screening in Low-Resource Settings
- Early Blood Test Patterns Linked to Three-Year Kidney Transplant Outcomes
- Molecular AI Model Refines Risk Prediction in Pediatric Brain Tumors
- Multiplex PCR Panel Gains FDA Clearance for Viral Hemorrhagic Fever Detection
- Genomic Profiling Predicts Relapse Risk by Subtype in Pediatric Leukemia
- Blood Test Identifies Early Breast and Prostate Cancer Signals Years Before Diagnosis
- Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer
- Liquid Biopsy Measures Tumor Burden and Identifies Small Cell Lung Cancer Subtypes
Channels
Clinical Chemistry
view channel
Blood Protein Signatures May Predict Brain Vessel Damage and Cognitive Decline
Cerebrovascular disease damages blood vessels in the brain and can contribute to tissue injury, microbleeds, white matter damage, stroke, cognitive decline, and dementia. Identifying people at higher risk... Read more
Flow Cytometry Tests Receive FDA Clearance for B-Cell Lymphoma Diagnosis
B-cell non-Hodgkin lymphoma (NHL), including chronic lymphocytic leukemia (CLL), requires accurate identification to guide further evaluation, monitoring, and treatment. In 2026, an estimated 79,320 people in the U.... Read moreHematology
view channel
New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients
Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more
Newly Certified FISH Probes Support Cytogenetic Testing in Blood Cancers
Hematological malignancies such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, chronic lymphoid leukemia, and multiple myeloma require assessment of key cytogenetic abnormalities.... Read more
Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification
Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read moreImmunology
view channel
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read more
Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways
Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read moreMicrobiology
view channel
Automated Microbial Identification and Susceptibility System Gains FDA Clearance
Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more
Gastrointestinal Flex Assay Gains EU Certification for Tailored Pathogen Testing
Gastrointestinal infections can be caused by bacterial, viral, or parasitic pathogens, making targeted test selection important for clinical laboratories. Fixed syndromic panels may be broader than necessary... Read more
Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing
Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. Symptoms such as diarrhea, vomiting,... Read morePathology
view channel
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more
Breakthrough-Designated Cytology Test Supports Oral Cancer Risk Assessment
Oral cavity and oropharyngeal cancers remain a significant diagnostic challenge, with more than 60,000 Americans expected to be diagnosed in 2026 and more than 13,000 expected to die from these cancers.... Read more
AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read moreTechnology
view channel
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read more
Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are... Read moreIndustry
view channel
Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business
Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Agilent Completes Acquisition of Digital Pathology Platform Developer Proscia
Agilent Technologies has completed its acquisition of Proscia, a provider of digital pathology software for clinical and life sciences applications. The transaction involved a cash payment of USD 240 million... Read more
New Diagnostics Company Onvaro Formed to Expand Decentralized Testing
Sapphiros, a diagnostics platform backed by investment funds managed by KKR, and binx health, a point-of-care diagnostics company backed by Hildred, have combined to form Onvaro. The new diagnostics company... Read more








